Although the incidence of BC is rare in men, carriers of the BRCA1/2 pathogenic variants have an increased risk of up to 10% (versus 0.1% in the general male population) and are also at higher risk for prostate cancer (15% vs. 6% in the general population). The gene discussed is BRCA1; the disease is breast cancer.